Drug Shortage Report for VINORELBINE TARTRATE FOR INJECTION

Last updated on 2018-05-08 History
Report ID 17779
Drug Identification Number 02271214
Brand name VINORELBINE TARTRATE FOR INJECTION
Common or Proper name VINORELBINE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) VINORELBINE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 5ML
ATC code L01CA
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2017-07-30
Estimated end date 2018-04-30
Actual end date 2018-05-01
Shortage status Resolved
Updated date 2018-05-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2018-05-08 French Compare
v7 2018-05-08 English Compare
v6 2018-03-20 French Compare
v5 2018-03-20 English Compare
v4 2017-12-19 English Compare
v3 2017-08-01 French Compare
v2 2017-08-01 English Compare
v1 2017-08-01 English Compare

Showing 1 to 8 of 8